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INTRODUCTION 
Helicobacter pylori is a bacterium that detaches from 
human beings all over the world, i.e., human being is the 
largest reservoir of this organism. In developing 
countries, up to age 10, 70 percent of people is colonized 
with this bacterium. The association of infection with the 
bacterium and occurrence of duodenal and gastric ulcers, 
cancer and gastric lymphoma is proven.
1-3 
Epidemiological studies show that the cumulative 
incidence of esophageal epithelial tumors, including 
squamous cell carcinoma and adenocarcinoma of the 
esophagus are increasing in many areas with a similar 
rate of prevalence and incidence.
4-6
 
 
Eslami et al in a study examined the relationship between 
Helicobacter-pylori and gastric cardia cancer and 
detected a very weak relationship between them.
7 
In the 
cardia and non-cardia gastric cancers the risk estimation 
of HP infection depends on study design, follow-up 
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Background: Helicobacter pylori is a bacterium that detaches from human beings all over the world, i.e., human 
being is the largest reservoir of this organism. The aim of this study was to investigate the prevalence of infection 
among patients with esophageal and gastric cardia cancers and healthy people. 
Methods: This case-control study was done on 144 persons who were divided into two groups (72 persons in each 
group). The control group included cases with normal endoscopy and the second group involved patients with gastric 
cardiac and distal esophageal cancer. Patients were sent to a lab to take stool samples. After receiving the lab reports, 
information was entered in the checklists and then was analyzed via statistical methods using SPSS 19.  
Results: The percentage of male cases in was 59.7% in case group and 48.6% in control group. The mean age of all 
patients was 64.2. In the case group 40.3% of patients were smokers and while this percentage was 23.6% in control 
group. The most common clinical symptom was dyspepsia in 94.4% of the patients. 27.8% of the individuals in the 
case group and 22.2% of those in control group were with positive gastrointestinal cancer history in family. 45.8% 
and 54.2% of patients were with cardia and distal esophageal cancer respectively. The incidence of H pylori infection 
in the case group was 37.5%, which was lower than the control group being 58.3% (p=0.012, OR=0.4, 0.2-0.8). 
Conclusions: The results showed that Helicobacter pylori infection may play a protective role in the development of 
esophageal and cardia cancers. 
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duration, age at diagnosis and HP genetic chain.
8-11 
The 
research studies on HP infection and esophageal 
malignancies/cancers have shown contradictory results 
indicating that the incidence rise of esophageal 
adenocarcinoma is more likely to be effect of the 
reduction in the prevalence of HP infection. 
Due to the high incidence of esophageal and gastric 
(cardia) cancers in Ardabil province, this study aimed at 
investigating the prevalence of infection among patients 
with esophageal cancer, gastric cardia and healthy people.  
METHODS 
This case-control study was undertaken over 144 patients 
who were assigned into two groups (control and case 
groups) with 72 cases in each one. The control group 
consisted of those with normal endoscopy and the case 
group included the patients with cancer of distal 
esophagus and gastric cardia cancer who were diagnosed 
and chosen for the study. The individuals in the control 
group were matched with the patients in the case group, 
in terms of age, sex and place of residence. Patients who 
met the inclusion criteria (having esophageal cancer, 
gastric cardia cancer, and normal endoscopy in the 
control group) were sent to the laboratory for providing 
stool samples. Subsequently, HP diagnostic tests were 
performed on the samples. The exclusion criteria were 
having a history of HP eradication, previous surgery on 
the stomach or the esophagus because of gastrointestinal 
cancers, being on antibiotics and PPI over the last month. 
Data obtained from the laboratory as well as patients' 
personal data, were employed to be analyzed by T-test 
and Chi-square, and descriptive statistical methods, using 
SPSS v19. Then the data were presented in the form of 
tables and graphs. In all tests, the significance level was 
considered less than 0.05. 
RESULTS 
The number of males was 43 (59.7%) in the case group 
and 35 (48.6%) in the control group. The mean age of 
patients was 66.7±9.4 in the case group, and 64.2±10.44 
in the control group. The age ranges of (70-80) in the 
case group and (50-60) in the control group were more 
common than other age ranges in terms of incidence of 
the cancer. There was no significant difference between 
individuals in two groups relating to height, weight and 
BMI. The results showed that 20 patients (27.8%) in the 
case group and 16 patients (22.2%) in the control group 
had a family history of cancer (Table 1). 
The most common symptom in patients with 
gastrointestinal cancer was dyspepsia that was seen in 68 
patients (94.44%) (Figure 1). The case group embraced 
33 patients (45.8%) with cardia cancer, and 39 patients 
(54.2%) with distal esophageal carcinoma. The most 
common involvement area in patients with cardia cancer 
was adenocarcinoma i.e., 25 out of 33 patients (75.8%), 
and in patients with distal esophageal carcinoma was 
SCC, i.e., 30 cases out of 39 patients (77%) (Figure 2). 
The results manifested that the incidence of HP infection 
in the case group (37.5%) was significantly lower than 
the control group, 58.3% (Figure 3) (OR = 0.4; CI = 0.2-
0.8). 
Regarding the location of the lesion in the case group, 
55.6% of the patients developed infection in the distal 
esophagus and 44/4% in the cardia which was not 
indicator of statistically significant difference between 
two locations. In the case group, the number of males 
with HP infection was greater than women, and this 
difference was statistically significant (P = 0.016) (Table 
2). The average age of infection was not significantly 
different between two groups 
 
Figure 1: Frequency of symptoms in case group 
 
 
Figure 2: The frequency of case group by involvement 
location. 
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Table 1: Demographic variables of study groups. 
Variables  
Case  Control  
p-value  
N % N % 
Sex  
Male 43 59.7 35 48.6 
0.18 
Female  29 30.3 37 51.4 
Education  
Illiterate  66 91.7 31 43 
0.001 
With-illiterate  6 8.3 41 57 
Family history of cancer 
+ 20 27.8 16 22.2 
0.001 
- 52 62.2 56 77.8 
Age groups 
<60 32 44.4 27 37.5 
0.148 60-70 15 20.8 13 18 
>70 25 34.8 32 44.5 
Job  
Employee 3 4.2 7 9.7 
0.38 House-keeper  26 36.1 27 37.5 
Self-employment  43 59.7 38 52.8 
Daily behavior  
Smoke use 29 40.3 17 23.6 
0.001 Tea use 27 37.5 54 75 
Alcohol and Opium use  16 21.2 1 1.4 
 
Table 2: Relation between sex and H-pylori                
incidence rate. 
Group \ Sex  
+ - p-
value  N % N % 
Case  
Male 21 48.8 22 51.2 
0.016 
Female  6 20.7 23 79.3 
Control  
Male  19 54.3 16 45.7 
0.498 
Female  23 62.2 14 37.8 
Total  
Male  40 51.3 38 48.7 
0.38 
Female  29 43.9 37 56.1 
 
Figure 3: H-pylori infection frequency in two                   
study groups. 
DISCUSSION 
The percentage of males was 59.7% in the case group and 
48.6% in the control group (P=0.181). The mean age of 
patients was 66.66 in the case group and 64.15 in the 
control group (P=0.240). The results of the present study 
were in line with those of other studies.
13,14
 In this study 
the incidence rate of infection in the case group was 
greater than that of the control (p=0.012). Furthermore, 
similar to other studies, it was observed that, two groups, 
totally, didn't have any meaningful relationship in terms 
of age (P=0.608), sex (P=0.380) and occurrence of HP 
infection.
13-15 
In the present study, no meaningful 
relationship was discovered between incidence of 
infection and the location of malignant lesion in the case 
group. Ye and colleagues in their study demonstrated that 
HP may lead to decreased risk of esophageal 
adenocarcinoma on the one hand; and increased risk of 
SCC for esophageal adenocarcinoma and cardia.
16
 They 
also showed that atrophy of the stomach is not a risk 
factor for adenocarcinoma and can increase the risk of 
esophageal SCC. Chow and colleagues
 
found no 
significant association between the incidence of HP 
infection and non-cardia gastric cancer (OR, 1.4; CI, 0.7-
2.8), but they showed that this infection could 
significantly reduce the incidence of cardia and 
esophageal cancers (OR, 0.4; CI, 0.2-0.8).
17
 In the study 
undertaken by Simán and colleagues, it was observed that 
the incidence of HP infection was significantly associated 
with gastric adenocarcinoma (OR = 17.8; 95% CI: 4.2-
74.8; 67), however, there was no relationship between 
adenocarcinoma of the esophagus and cardia and HP 
infection and Cag A.
18
 Although the study conducted by 
de Martel et al illustrated significant relationship between 
the incidence of esophageal cancer and smoking 
(p=0.003) and BMI (P=0.003), it couldn't detect any 
meaningful relationship between alcohol consumption, 
education, HP serology and Cag A serology, and the 
incidence of esophageal cancer. Wu et al in a study 
showed that smoking, BMI, being seropositive for HP 
increases the risk of non-cardia gastric cancer, and this 
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rise is accompanied by the increase of Cag A (OR = 1.85, 
CI = 1.03, 3.32) but does not heighten the risk of 
developing esophageal and cardia cancers.
19
 It was also 
observed that when HP accompanies Cag A, the 
incidence rate of esophageal and cardia cancers does not 
increase, but this association entails the increased 
incidence of non-cardia gastric cancer. In a study, Wu et 
al also revealed that HP infection lowers the incidence 
rate of esophageal SCC, whereas it significantly raises 
the incidence rate of cardia and non-cardia gastric cancers 
in comparison to colon cancer.
20
 No association was 
found between the incidence of infection and esophageal 
SCC. In the study conducted by Anderson et al a 
relationship between decrease in the incidence of 
esophageal adenocarcinoma and being seropositive for 
HP has been reported (OR = 0.49; CI: 0.3,0.7).
21
 It was 
also observed that atrophic gastritis in patients with 
esophageal adenocarcinoma was lower than control 
subjects, but this reduction was not statistically 
significant. Whiteman et al in their study observed that 
the incidence of esophageal adenocarcinoma (OR = 0.45; 
CI: 0.3-0.7) and cardia (OR = 0.4; CI: 0.3-0.6) was lower 
in patients with HP infection; however, the incidence of 
HP infection didn't have relationship with esophageal 
SCC.
22
  
CONCLUSION 
The results of the present study in similar to other studies 
showed that the rate of HP infection in patients with 
esophageal distal cancer and cardia significantly lower 
than control group. There was a positive relation between 
Helicobacter pylori infection and decreasing esophageal 
distal cancer and cardia. 
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